AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China
AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.
AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.